Invest-NL says Dutch biotech gains edge by linking with high-tech sector, analysis finds

Invest-NL says Dutch biotech can strengthen its position by linking more tightly with high-tech industries.

• The report flags measurement, data analysis, automation, process development, and production capacity as key constraints on scaling biotech beyond the lab.
• It identifies investable “enabling” technologies aligned with Dutch strengths in precision engineering, photonics, semiconductor equipment, and systems integration.
• The analysis calls for shared national infrastructure for experimentation, measurement, process development, and scale-up to shorten timelines and reduce fragmentation across startups.
• The deep dive launches a four-part biotech series that will map investment opportunities, scale-up barriers, and solutions across agrifood, health, and industrial biotech.